2024-03-012025-02-282025-02-28false04633828HICKORY HOUSE NURSERY LIMITED2025-11-03falseiso4217:GBPxbrli:pure046338282024-02-29046338282025-02-28046338282024-03-012025-02-28046338282023-02-28046338282024-02-29046338282023-03-012024-02-2904633828bus:SmallEntities2024-03-012025-02-2804633828bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2804633828bus:FullAccounts2024-03-012025-02-2804633828bus:PrivateLimitedCompanyLtd2024-03-012025-02-2804633828core:WithinOneYear2025-02-2804633828core:AfterOneYear2025-02-2804633828core:WithinOneYear2024-02-2904633828core:AfterOneYear2024-02-2904633828core:ShareCapital2025-02-2804633828core:SharePremium2025-02-2804633828core:RevaluationReserve2025-02-2804633828core:OtherReservesSubtotal2025-02-2804633828core:RetainedEarningsAccumulatedLosses2025-02-2804633828core:ShareCapital2024-02-2904633828core:SharePremium2024-02-2904633828core:RevaluationReserve2024-02-2904633828core:OtherReservesSubtotal2024-02-2904633828core:RetainedEarningsAccumulatedLosses2024-02-2904633828core:LandBuildings2025-02-2804633828core:PlantMachinery2025-02-2804633828core:Vehicles2025-02-2804633828core:FurnitureFittings2025-02-2804633828core:OfficeEquipment2025-02-2804633828core:NetGoodwill2025-02-2804633828core:IntangibleAssetsOtherThanGoodwill2025-02-2804633828core:ListedExchangeTraded2025-02-2804633828core:UnlistedNon-exchangeTraded2025-02-2804633828core:LandBuildings2024-02-2904633828core:PlantMachinery2024-02-2904633828core:Vehicles2024-02-2904633828core:FurnitureFittings2024-02-2904633828core:OfficeEquipment2024-02-2904633828core:NetGoodwill2024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2024-02-2904633828core:ListedExchangeTraded2024-02-2904633828core:UnlistedNon-exchangeTraded2024-02-2904633828core:LandBuildings2024-03-012025-02-2804633828core:PlantMachinery2024-03-012025-02-2804633828core:Vehicles2024-03-012025-02-2804633828core:FurnitureFittings2024-03-012025-02-2804633828core:OfficeEquipment2024-03-012025-02-2804633828core:NetGoodwill2024-03-012025-02-2804633828core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2804633828core:ListedExchangeTraded2024-03-012025-02-2804633828core:UnlistedNon-exchangeTraded2024-03-012025-02-2804633828core:MoreThanFiveYears2024-03-012025-02-2804633828core:Non-currentFinancialInstruments2025-02-2804633828core:Non-currentFinancialInstruments2024-02-2904633828dpl:CostSales2024-03-012025-02-2804633828dpl:DistributionCosts2024-03-012025-02-2804633828core:LandBuildings2024-03-012025-02-2804633828core:PlantMachinery2024-03-012025-02-2804633828core:Vehicles2024-03-012025-02-2804633828core:FurnitureFittings2024-03-012025-02-2804633828core:OfficeEquipment2024-03-012025-02-2804633828dpl:AdministrativeExpenses2024-03-012025-02-2804633828core:NetGoodwill2024-03-012025-02-2804633828core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2804633828dpl:GroupUndertakings2024-03-012025-02-2804633828dpl:ParticipatingInterests2024-03-012025-02-2804633828dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2804633828core:ListedExchangeTraded2024-03-012025-02-2804633828dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2804633828core:UnlistedNon-exchangeTraded2024-03-012025-02-2804633828dpl:CostSales2023-03-012024-02-2904633828dpl:DistributionCosts2023-03-012024-02-2904633828core:LandBuildings2023-03-012024-02-2904633828core:PlantMachinery2023-03-012024-02-2904633828core:Vehicles2023-03-012024-02-2904633828core:FurnitureFittings2023-03-012024-02-2904633828core:OfficeEquipment2023-03-012024-02-2904633828dpl:AdministrativeExpenses2023-03-012024-02-2904633828core:NetGoodwill2023-03-012024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2904633828dpl:GroupUndertakings2023-03-012024-02-2904633828dpl:ParticipatingInterests2023-03-012024-02-2904633828dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2904633828core:ListedExchangeTraded2023-03-012024-02-2904633828dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2904633828core:UnlistedNon-exchangeTraded2023-03-012024-02-2904633828core:NetGoodwill2025-02-2804633828core:IntangibleAssetsOtherThanGoodwill2025-02-2804633828core:LandBuildings2025-02-2804633828core:PlantMachinery2025-02-2804633828core:Vehicles2025-02-2804633828core:FurnitureFittings2025-02-2804633828core:OfficeEquipment2025-02-2804633828core:AfterOneYear2025-02-2804633828core:WithinOneYear2025-02-2804633828core:ListedExchangeTraded2025-02-2804633828core:UnlistedNon-exchangeTraded2025-02-2804633828core:ShareCapital2025-02-2804633828core:SharePremium2025-02-2804633828core:RevaluationReserve2025-02-2804633828core:OtherReservesSubtotal2025-02-2804633828core:RetainedEarningsAccumulatedLosses2025-02-2804633828core:NetGoodwill2024-02-2904633828core:IntangibleAssetsOtherThanGoodwill2024-02-2904633828core:LandBuildings2024-02-2904633828core:PlantMachinery2024-02-2904633828core:Vehicles2024-02-2904633828core:FurnitureFittings2024-02-2904633828core:OfficeEquipment2024-02-2904633828core:AfterOneYear2024-02-2904633828core:WithinOneYear2024-02-2904633828core:ListedExchangeTraded2024-02-2904633828core:UnlistedNon-exchangeTraded2024-02-2904633828core:ShareCapital2024-02-2904633828core:SharePremium2024-02-2904633828core:RevaluationReserve2024-02-2904633828core:OtherReservesSubtotal2024-02-2904633828core:RetainedEarningsAccumulatedLosses2024-02-2904633828core:NetGoodwill2023-02-2804633828core:IntangibleAssetsOtherThanGoodwill2023-02-2804633828core:LandBuildings2023-02-2804633828core:PlantMachinery2023-02-2804633828core:Vehicles2023-02-2804633828core:FurnitureFittings2023-02-2804633828core:OfficeEquipment2023-02-2804633828core:AfterOneYear2023-02-2804633828core:WithinOneYear2023-02-2804633828core:ListedExchangeTraded2023-02-2804633828core:UnlistedNon-exchangeTraded2023-02-2804633828core:ShareCapital2023-02-2804633828core:SharePremium2023-02-2804633828core:RevaluationReserve2023-02-2804633828core:OtherReservesSubtotal2023-02-2804633828core:RetainedEarningsAccumulatedLosses2023-02-2804633828core:AfterOneYear2024-03-012025-02-2804633828core:WithinOneYear2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804633828core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2804633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2804633828core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2904633828core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2904633828core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2904633828bus:Director12024-03-012025-02-2804633828core:FurnitureFittingsToolsEquipment2024-02-2904633828core:FurnitureFittingsToolsEquipment2025-02-2804633828core:FurnitureFittingsToolsEquipment2024-03-012025-02-28

HICKORY HOUSE NURSERY LIMITED

Registered Number
04633828
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

HICKORY HOUSE NURSERY LIMITED
Company Information
for the year from 1 March 2024 to 28 February 2025

Director

Sharon Cecilia Crofts

Company Secretary

James Leigh Crofts

Registered Address

5 High Street
Daventry
Northants
NN11 4BG

Registered Number

04633828 (England and Wales)
HICKORY HOUSE NURSERY LIMITED
Balance Sheet as at
28 February 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets4327,367327,786
327,367327,786
Current assets
Debtors57,8528,097
Cash at bank and on hand184,555161,949
192,407170,046
Creditors amounts falling due within one year6(75,363)(59,168)
Net current assets (liabilities)117,044110,878
Total assets less current liabilities444,411438,664
Creditors amounts falling due after one year7(66,652)(120,808)
Provisions for liabilities8(419)(524)
Net assets377,340317,332
Capital and reserves
Called up share capital100100
Profit and loss account377,240317,232
Shareholders' funds377,340317,332
The financial statements were approved and authorised for issue by the Director on 3 November 2025, and are signed on its behalf by:
Sharon Cecilia Crofts
Director
Registered Company No. 04633828
HICKORY HOUSE NURSERY LIMITED
Notes to the Financial Statements
for the year ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings20
Office Equipment20
2.Average number of employees

20252024
Average number of employees during the year1413
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 March 2430,00030,000
At 28 February 2530,00030,000
Amortisation and impairment
At 01 March 2430,00030,000
At 28 February 2530,00030,000
Net book value
At 28 February 25--
At 29 February 24--
4.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 March 24323,6882,0019,275929335,893
At 28 February 25323,6882,0019,275929335,893
Depreciation and impairment
At 01 March 24--7,7723358,107
Charge for year--301118419
At 28 February 25--8,0734538,526
Net book value
At 28 February 25323,6882,0011,202476327,367
At 29 February 24323,6882,0011,503594327,786
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables5,9866,502
Other debtors16-
Prepayments and accrued income1,8501,595
Total7,8528,097
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-128
Bank borrowings and overdrafts11,13111,969
Taxation and social security35,39520,673
Other creditors24,06921,146
Accrued liabilities and deferred income4,7685,252
Total75,36359,168
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts66,652120,808
Total66,652120,808
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)419524
Total419524